Japan Colorectal Cancer Diagnostics Market Size, Share, and COVID-19 Impact Analysis, By Test Types (Stool-Based Tests, Imaging Tests, Biopsy, Blood-Based Tests, and Others), By End-Users (Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers, and Others), and Japan Colorectal Cancer Diagnostics Market Insights, Industry Trend, Forecasts to 2033

Japan Colorectal Cancer Diagnostics Market Insights Forecasts to 2033

• The Japan Colorectal Cancer Diagnostics Market Size was Valued at USD 523.39 Million in 2023
• The Market Size is Growing at a CAGR of 4.83% from 2023 to 2033
• The Japan Colorectal Cancer Diagnostics Market Size is Expected to Reach USD  839.23 Million by 2033

The Japan Colorectal Cancer Diagnostics Market Size is Anticipated to Reach USD 839.23 Million by 2033, growing at a CAGR of 4.83% from 2023 to 2033.

Market Overview

The industry committed to creating and supplying diagnostic instruments and technology for the detection of colorectal cancer in Japan is known as the Japan colorectal cancer diagnostics market. This market covers a range of diagnostic procedures, including liquid biopsies, stool DNA testing, colonoscopies, fecal occult blood tests (FOBT), and sophisticated imaging technologies. The increasing incidence of colorectal cancer in Japan, which emphasizes the pressing need for efficient diagnostic tools, is one of the main growth factors propelling this market. Technological developments in diagnostic techniques are another important driver of growth in Japan. The precision and effectiveness of colorectal cancer detection in Japan are being improved by innovations including liquid biopsy, sophisticated imaging methods, and AI-based diagnostic systems. In Japan, the use of AI in diagnostics is especially notable since it helps with accurate and timely medical imaging analysis, increasing the likelihood of early detection. Diagnostics are becoming more accessible and dependable due to these technological advancements, which are helping the Japanese market expand. In Japan, government programs and public awareness campaigns are also quite important. In order to increase survival rates, the nation has been putting in place nationwide screening programs for colorectal cancer, which are essential for early detection.

Report Coverage

This research report categorizes the market for the Japan colorectal cancer diagnostics market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan colorectal cancer diagnostics market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan colorectal cancer diagnostics market.

Driving Factors

Ageing populations, lifestyle choices, and genetic predispositions are some of the factors contributing to the rise in colorectal cancer cases in Japan. Given that the incidence of colorectal cancer rises with age, Japan's aging population is a major factor. The need for diagnostic instruments that can precisely identify colorectal cancer in its early stages has increased due to the global demographic shift towards older age groups, especially in Japan. The demand for diagnostic testing is further fueled by the fact that greater incidence rates of colorectal cancer in Japan have been related to sedentary lifestyles, poor dietary habits, and increased intake of processed foods. To address this rising issue, Japan's healthcare industry is aggressively investing in cutting-edge screening technologies, demonstrating the nation's dedication to enhancing cancer diagnosis and treatment results. Additionally, about 10% of men and 8% of women in Japan are predicted to receive a colorectal cancer diagnosis at some point in their lives, making it a serious health risk. The market is also being driven by the growing incidence of colorectal cancer cases in Japan, which is raising the need for early detection tools and sophisticated diagnostic technologies.

Restraining Factors

The high expense of sophisticated diagnostic procedures and technology is one of the main barriers. Diagnostic advancements are increasing precision and early detection rates, but they are frequently expensive.

Market Segmentation

The Japan colorectal cancer diagnostics market share is classified into test types and end-users.

• The stool-based tests segment is expected to hold a significant market share through the forecast period.

The Japan colorectal cancer diagnostics market is segmented by test types into stool-based tests, imaging tests, biopsy, blood-based tests, and others. Among these, the stool-based tests segment is expected to hold a significant market share through the forecast period. Initial screening frequently involves stool-based testing, such as fecal occult blood tests (FOBT) and fecal immunochemical assays (FIT). Because these tests are non-invasive and reasonably priced, both patients and healthcare professionals favor them.

• The hospitals segment is expected to hold a significant market share through the forecast period.

The Japan colorectal cancer diagnostics market is segmented by end-users into hospitals, diagnostic laboratories, ambulatory surgical centers, and others. Among these, the hospitals segment is expected to hold a significant market share through the forecast period. This is due to their substantial market share, hospitals are the main end consumers. To ensure a smooth patient experience, they offer all diagnostic services under one roof, including biopsies and sophisticated imaging.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan colorectal cancer diagnostics market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• F. Hoffmann-La Roche Ltd.
• Abbott
• Illumina
• QIAGEN
• Thermo Fisher Scientific Inc.
• Quest Diagnostics Incorporated
• Merck KGaA
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Japan Colorectal Cancer Diagnostics Market based on the below-mentioned segments:

Japan Colorectal Cancer Diagnostics Market, By Test Types

• Stool-Based Tests
• Imaging Tests
• Biopsy
• Blood-Based Tests
• Others

Japan Colorectal Cancer Diagnostics Market, By End-Users

• Hospitals
• Diagnostic Laboratories
• Ambulatory Surgical Centers
• Others